RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Medel

Company

Russian developer of medical products.

Owners:
Axioma Capital Partners

Content

Owners

Principal direction of work of a startup (April, 2014) - creation of medical products for treatment of arthroses of joints on the basis of the patented technology. According to the developer, the created solution significantly reduces the cost and terms of treatment and recovery of patients and is on real an alternative of operation on replacement of a joint.

History

2012: Entry into an incubator Ingria

In November, 2012 the Medel project became the resident of business incubator Ingria.

2013: Receiving assessment And in Russian Startup Rating

In 2013 the resident received assessment And in Russian Startup Rating and entered in top-50 the Russian startups. Advanced development interested in Fund of preseeding investments, RVC, the Northwest center of a transfer of the technologies offering partial financing of the project.

2014 Investments of $4 million from Axioma Capital Partners

In April, 2014 the resident of Business incubator Ingria - the MEDEL company closed the investment transaction with Axioma Capital Partners investment company. According to the results of the agreement the startup will receive 4 million dollars of investments on commercialization of advanced development of "MEDEL". According to the results of negotiations with Axioma Capital Partners, the parties agreed about complete financing and closed the investment transaction.

Representative of Axioma Capital Partners investment company:

"We are interested in development of this and other developments of "MEDEL" as the method of treatment created by the project is extremely demanded and has high potential. Now from the budget of the Russian Federation about 10 billion rubles are annually selected for operations on endoprosthesis replacement of the joints destroyed by arthrosis – I believe that the state, insurance companies and patients will be interested in an opportunity to use the solution, effective from the medical and financial points of view".

Mikhail Morgunov, MEDEL project manager:

"The history of our development began in 1979 in Army medical college. We conducted pioneer researches of influence of electric field of electrets on processes of recovery of a bone tissue after injuries and diseases, including on recovery of functions of the joints affected with arthrosis. The created stimulators of an osteoreparation underwent broad clinical approbation and showed high efficiency. However due to the lack of financing further development of development was stopped".

Links

Presentation of the MEDEEL project